Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke - Schneider, Dietmar; Brandt, Tobias; Hacke, Werner (European neurology, 1998)
Gesehen am: 26.05.2025